Tibet Duo Rui Pharmaceutical Co., Ltd. (SHE:301075)
China
· Delayed Price · Currency is CNY 94.31
+3.79 (4.19%)
At close: Mar 10, 2026
SHE:301075 Revenue
Tibet Duo Rui Pharmaceutical had revenue of 30.43M CNY in the quarter ending September 30, 2025, a decrease of -39.32%. This brings the company's revenue in the last twelve months to 177.11M, down -38.62% year-over-year. In the year 2024, Tibet Duo Rui Pharmaceutical had annual revenue of 240.63M, down -28.02%.
Revenue (ttm)
177.11M
Revenue Growth
-38.62%
P/S Ratio
42.04
Revenue / Employee
356.35K
Employees
497
Market Cap
7.45B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shanghai Kaibao Pharmaceutical CO.,Ltd | 1.17B |
| ChengDa Pharmaceuticals | 374.46M |
| Jiangsu Lianhuan Pharmaceutical | 2.60B |
| Beijing SL Pharmaceutical | 578.61M |
| Beijing Sun-Novo Pharmaceutical Research | 1.22B |
| Jinghua Pharmaceutical Group | 1.45B |
| Guizhou Xinbang Pharmaceutical | 5.73B |
| Guizhou Bailing Group Pharmaceutical | 3.15B |